| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |